SYFa190ba7be2824613a9e6766f033deed5

RecruitingPhase 1

A Phase 1 first-in-human study to evaluate SAR448272 in adul...

Sanofi-Aventis Recherche & DeveloppementSource

Compare

Other study identifiers

Secondary identifiers

U1111-1336-2172

Study Type

interventional

Reported enrollment (type unavailable)

N/A

Locations

5 countries

Sites

8

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: recruiting
Reported enrollment (type unavailable): Not reported
Study completion date: Not reported
Date not reported
Listed locations: 5 countries · 8 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
April 15, 2026
Actual (reported)

Conditions

healthy volunteers immunological diseases

Sponsors & Collaborators

Sanofi-Aventis Recherche & Developpement
Industrylead

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Study Sites (8)

Fakultni Nemocnice Kralovske Vinohrady

Prague, 100 00, Czechia

Spyridon Gkalpakiotis+420267163000 spyridon.gkalpakiotis@fnkv.cz

Pratia Czech s.r.o.

Pardubice I, 530 02, Czechia

Andrea Bartlova+420608450819 andrea.bartlova@pratia.com

Centre Hospitalier Regional De Marseille

Marseille, 13005, France

Florent Amatore491964518

Central Study Contacts

Clinical Sciences and Operations

+8006331610 contact-us@sanofi.com

Study Design

Study Type: interventional
Phase: phase 1

Study Record Dates

First Submitted

April 15, 2026

Source record

Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: 2026-526014-87-00
Data provider: European Medicines Agency (EMA)
Normalization version: ctis-v1

Open registry record

Source retrieved: 2026-10-30 06:54:56 UTC

Locations

CZ(2)DE(1)

NCT07024589

First-in-Human Trial of Oral AN2-502998

Phase 1Completed

NCT07580794

First-in-human Study of HSK56630 in Healthy Subjects

Phase 1Recruiting

NCT04105205

First-In-Human Study of Apramycin

Phase 1Completed

NCT07432698

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants

Phase 1Active Not Recruiting

NCT07240675

Single-dose,First-in-human of KLA478

Phase 1Recruiting

NCT06360640

A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Phase 1Completed

Florent.amatore@ap-hm.fr

Hospital Universitari Vall D Hebron

Barcelona, 08035, Spain

Gloria Aparicio Español34934893000 mariagloria.aparicio@vallhebron.cat

Hospital Universitario Reina Sofia

Cordoba, 14004, Spain

Juan Alberto Ruano Ruiz34957010265 juanruanoruiz@mac.com

Centro Ricerche Cliniche Di Verona S.r.l.

Verona, 37134, Italy

Francesco Bellinato00390458122547 francesco.bellinato@univr.it

I.F.O. Istituti Fisioterapici Ospitalieri

Rome, 00144, Italy

Maria Concetta Fargnoli00390652665283 mariaconcetta.fargnoli@ifo.it

Charite Research Organisation GmbH

Berlin, 10117, Germany

Joana Crespo Martins+4930450539200 Joana.Crespo-Martins@charite-research.org

ES

(2)

FR(1)

IT(2)

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Conditions

Sponsors & Collaborators

Study Sites (8)

Central Study Contacts

Study Design

Study Record Dates

Source record

Locations